Inactive Instrument

Calendar Ritter Pharmaceuticals Inc Nasdaq

Equities

US7678361095

Chart calendar Ritter Pharmaceuticals Inc

9bb8a5786a0130.Tfs56FumJjpl4TqzGFYDVNrlV-uvr-CWN_k6OcYz6MM.HIN9hB7eYWguj1XUfi9yPZCOId375rH7WYlsT_ZkxZE4nG6qGvx_CjyUfw~df10e23f88c74152fdc78b41cd464791

Upcoming events on Ritter Pharmaceuticals Inc

12/08/2024 Q2 2024 Earnings Release (Projected)

Past events on Ritter Pharmaceuticals Inc

09/05/2024 Q1 2024 Earnings Release (Projected)
04/04/2024 American Association for Cancer Research Meeting - Abstract #3320
04/04/2024 American Association for Cancer Research Meeting - Abstract Number - #3350
04/04/2024 American Association for Cancer Research Meeting - Abstract Number - #5928
04/04/2024 American Association for Cancer Research Meeting - Abstract Number - #105
04/04/2024 American Association for Cancer Research Meeting - Abstract Number - #576
21/10/2023 American Association for Cancer Research in Breast Cancer Conference - Abstract :#B020
26/09/2023 AACR Special Conference in Cancer Research: Pancreatic Cancer - Poster Number A080
26/09/2023 AACR Special Conference in Cancer Research: Pancreatic Cancer - Poster Number A081
15/08/2023 13:30 Q2 2023 Earnings Release
12/07/2023 Annual General Meeting
01/06/2023 American Society of Clinical Oncology Conference - A novel pan-RAS
01/06/2023 American Society of Clinical Oncology Conference - Impact of novel pan-RAS
16/05/2023 13:00 Q1 2023 Earnings Release
02/05/2023 21:30 Q4 2022 Earnings Release
13/04/2023 American Association for Cancer Research Meeting - Abstract No: 2708
04/03/2023 American Association for Cancer Research Special Conference - A Novel RAS inhibitor for Pancreatic C
04/03/2023 American Association for Cancer Research Special Conference - A Novel RAS Inhibitor for Luminal B an
15/11/2022 12:30 Q3 2022 Earnings Release
26/10/2022 20:30 LD Micro Main Event Conference

Annual results

Fiscal PeriodDecember 2021 2022 2023 2024
Net sales
Million USD
Released
Forecast
Spread
5,65
5,51
2.61%
4,98
5,17
-3.64%
3,66
3,20
14.41%

0,00

EBITDA
Released
Forecast
Spread
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-

0,00

EBIT
Million USD
Released
Forecast
Spread
-22,7
-24,0
5.39%
-17,9
-18,5
3.23%
-11,3
-12,7
10.99%

-11,0

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-17,9
-18,8
4.83%
-21,3
-18,9
-12.7%
-12,5
-13,8
9.57%

-11,0

Net income
Million USD
Released
Forecast
Spread
-17,9
-17,8
-0.52%
-18,6
-17,9
-4.38%
-13,4
-13,8
2.77%

-11,0

EPS
USD
Released
Forecast
Spread
-6,10
-6,15
0.81%
-4,85
-4,76
-1.89%
-2,65
-2,70
1.85%

-1,00

Announcement Date31/03/2202/05/2308/04/24-

Quarterly results

Fiscal PeriodDecember 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4
Net sales
Million USD
Released
Forecast
Spread
1,48
1,32
11.88%
0,72
0,86
-16.09%
1,43
1,20
19.21%
1,44
1,62
-11.05%
1,39
1,58
-11.75%
1,61
1,40
14.8%
1,63
1,60
1.69%
0,43
0,50
-14.62%
0,00
0,00
-
EBIT
Million USD
Released
Forecast
Spread
-4,65
-5,95
21.83%
-5,01
-5,86
14.56%
-4,14
-5,51
24.9%
-4,38
-5,43
19.21%
-4,41
-5,03
12.25%
-3,69
-4,55
18.84%
-3,55
-4,40
19.29%
-2,78
-4,90
43.3%
-2,27
-2,70
15.78%
Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-6,06
-7,00
13.46%
-4,32
-6,80
36.48%
-4,12
-6,20
33.51%
-4,06
-6,10
33.51%
-8,80
-5,50
-60.05%
-4,27
-4,60
7.15%
-3,55
-4,40
19.41%
-3,24
-4,90
33.98%
-2,47
-2,70
8.43%
Net income
Million USD
Released
Forecast
Spread
-6,06
-7,00
13.42%
-4,32
-6,80
36.47%
-4,12
-6,20
33.49%
-3,83
-6,10
37.29%
-6,37
-5,03
-26.8%
-3,85
-4,60
16.39%
-3,46
-4,20
17.52%
-3,66
-4,70
22.2%
-2,45
-2,70
9.25%
EPS
USD
Released
Forecast
Spread
-2,00
-2,40
16.67%
-1,20
-1,90
36.84%
-1,10
-1,80
38.89%
-1,00
-1,60
37.5%
-1,55
-1,25
-24%
-0,78
-0,85
8.24%
-0,69
-0,52
-32.69%
-0,72
-0,92
21.74%
-0,47
-0,52
9.62%
Announcement Date31/03/2213/05/2215/08/2214/11/2202/05/2315/05/2314/08/2314/11/2308/04/24

Past sector events for Ritter Pharmaceuticals Inc

  1. Stock Market
  2. Equities
  3. QLGN Stock
  4. Stock
  5. Calendar Ritter Pharmaceuticals Inc